Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Invested Capital (2016 - 2025)

iBio (IBIO) has disclosed Invested Capital for 15 consecutive years, with $56.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital rose 302.56% to $56.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.6 million, a 302.56% increase, with the full-year FY2025 number at $14.9 million, down 30.5% from a year prior.
  • Invested Capital was $56.6 million for Q4 2025 at iBio, up from $56.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $108.6 million in Q2 2021 to a low of $9.2 million in Q4 2023.
  • A 5-year average of $44.4 million and a median of $23.2 million in 2024 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: skyrocketed 2549.23% in 2021, then crashed 79.22% in 2022.
  • iBio's Invested Capital stood at $90.6 million in 2021, then plummeted by 79.22% to $18.8 million in 2022, then plummeted by 51.14% to $9.2 million in 2023, then surged by 52.77% to $14.0 million in 2024, then skyrocketed by 302.56% to $56.6 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Invested Capital are $56.6 million (Q4 2025), $56.1 million (Q3 2025), and $14.9 million (Q2 2025).